» Articles » PMID: 19726636

Presynaptic and Postsynaptic Interaction of the Amyloid Precursor Protein Promotes Peripheral and Central Synaptogenesis

Overview
Journal J Neurosci
Specialty Neurology
Date 2009 Sep 4
PMID 19726636
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

A critical role of the amyloid precursor protein (APP) in Alzheimer's disease (AD) pathogenesis has been well established. However, the physiological function of APP remains elusive and much debated. We reported previously that the APP family of proteins is essential in mediating the developing neuromuscular synapse. In the current study, we created a conditional allele of APP and deleted APP in presynaptic motor neuron or postsynaptic muscle. Crossing these alleles onto the APP-like protein 2-null background reveals that, unexpectedly, inactivating APP in either compartment results in neuromuscular synapse defects similar to the germline deletion and that postsynaptic APP is obligatory for presynaptic targeting of the high-affinity choline transporter and synaptic transmission. Using a HEK293 and primary hippocampus mixed-culture assay, we report that expression of APP in HEK293 cells potently promotes synaptogenesis in contacting axons. This activity is dependent on neuronal APP and requires both the extracellular and intracellular domains; the latter forms a complex with Mint1 and Cask and is replaceable by the corresponding SynCAM (synaptic cell adhesion molecule) sequences. These in vitro and in vivo studies identify APP as a novel synaptic adhesion molecule. We postulate that transsynaptic APP interaction modulates its synaptic function and that perturbed APP synaptic adhesion activity may contribute to synaptic dysfunction and AD pathogenesis.

Citing Articles

Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer's Disease.

Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y Int J Mol Sci. 2025; 26(1.

PMID: 39796257 PMC: 11721675. DOI: 10.3390/ijms26010403.


The AICD interactome: implications in neurodevelopment and neurodegeneration.

Ng L, Chow J, Lau K Biochem Soc Trans. 2024; 52(6):2539-2556.

PMID: 39670668 PMC: 11668293. DOI: 10.1042/BST20241510.


Effects and mechanisms of APP and its cleavage product Aβ in the comorbidity of sarcopenia and Alzheimer's disease.

Wu J, Tang J, Huang D, Wang Y, Zhou E, Ru Q Front Aging Neurosci. 2024; 16:1482947.

PMID: 39654807 PMC: 11625754. DOI: 10.3389/fnagi.2024.1482947.


The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer's Disease Etiopathology.

Fanlo-Ucar H, Picon-Pages P, Herrera-Fernandez V, Ill-Raga G, Munoz F Antioxidants (Basel). 2024; 13(10).

PMID: 39456461 PMC: 11505517. DOI: 10.3390/antiox13101208.


Alzheimer's disease and its treatment-yesterday, today, and tomorrow.

Kim A, Al Jerdi S, MacDonald R, Triggle C Front Pharmacol. 2024; 15:1399121.

PMID: 38868666 PMC: 11167451. DOI: 10.3389/fphar.2024.1399121.


References
1.
Selkoe D . Alzheimer's disease is a synaptic failure. Science. 2002; 298(5594):789-91. DOI: 10.1126/science.1074069. View

2.
Sanes J, Lichtman J . Development of the vertebrate neuromuscular junction. Annu Rev Neurosci. 1999; 22:389-442. DOI: 10.1146/annurev.neuro.22.1.389. View

3.
Wang P, Yang G, Mosier D, Chang P, Zaidi T, Gong Y . Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci. 2005; 25(5):1219-25. PMC: 6725967. DOI: 10.1523/JNEUROSCI.4660-04.2005. View

4.
Zheng H, Koo E . The amyloid precursor protein: beyond amyloid. Mol Neurodegener. 2006; 1:5. PMC: 1538601. DOI: 10.1186/1750-1326-1-5. View

5.
Osterfield M, Egelund R, Young L, Flanagan J . Interaction of amyloid precursor protein with contactins and NgCAM in the retinotectal system. Development. 2008; 135(6):1189-99. DOI: 10.1242/dev.007401. View